Real-time monitoring of levodopa levels in Parkinson’s
Part of Brain & nervous system clinical trials.
This study checks whether measuring levodopa (a Parkinson medicine) in real time can help better understand Parkinson medication effects. You may be asked to wear/perform study monitoring while taking your usual carbidopa/levodopa tablets.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have Parkinson’s disease that meets the official “clinically established” diagnosis rules.
- You can sign consent in English or Spanish.
- Your Parkinson’s is mild to severe, and you can walk (Hoehn and Yahr stage I–IV).
- You take carbidopa/levodopa as an immediate-release pill by mouth (not another form).
- You are either not taking, or are on a stable dose of certain add-on Parkinson medicines (dopamine agonists, MAO-B inhibitors, or COMT inhibitors).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special test to look at dopamine levels in the brain of people with Parkinson's disease. It may help doctors understand the disease better and could lead to better treatments.
This study tests whether adjusting the ratio of carbidopa and levodopa (medications used for Parkinson's) can help reduce dizziness or fainting from low blood pressure when standing up, in people with Multiple System Atrophy (Parkinsonian type) or Parkinson's disease.
This trial tests a new management approach using remote monitoring via smartphone or tablet to help people with Parkinson's better manage their condition. It aims to see if this tool improves care compared to standard follow-up.
This trial tests a remote way to assess people newly diagnosed with Parkinson's disease, to help monitor their condition and guide care.
This study is looking at how a new continuous 24-hour injection treatment (foslevodopa/foscarbidopa) affects quality of life in people with advanced Parkinson's disease. It is a real-world study, meaning you just take the medication as your doctor prescribes, and researchers observe the results.
This trial tests an experimental drug called AP-472, taken alongside your regular Parkinson's medications, to see if it can reduce the amount of "OFF" time you experience each day when symptoms return between doses of levodopa.
Hear when a new Parkinson Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.